LRRK2 and Parkinson disease: The first two in-depth reports of PD modeling in hMO focused on the effects of the LRRK2 G2019S mutation, which has been associated with both sporadic and familial forms of the disease due to its variable penetrance (31), and which constitutes the most common genetic risk factor for PD.